# K944076: CX (TM) Benzodiazepine (Benz) Reagent for Sychron CX Sys

- Pathway: 510(k) (Traditional)
- Applicant: Beckman Instruments, Inc.
- Decided: Nov 21, 1994 after 139 days
- Product code: JXM (Enzyme Immunoassay, Benzodiazepine)
- Device class: 2
- Regulation: 21 CFR 862.3170
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
3 later devices descend from it; 1 cites it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K023048: Modification to Synchron Systems Benzodiazepine Reagent (2002), 2 descendants of its own
- K051307: Synchron Systems Bebzodiazapine (Ebnz) Reagent (2005), 0 descendants of its own
- K043556: Synchron Systems Benzodiazepine (BNZG) Reagent (2005), 0 descendants of its own

Source page: https://510kreport.com/device/K944076
Methodology: https://510kreport.com/methodology